Unilever PLC shares rise as Q4 and full-year 2025 results released
Shares of Unilever PLC (UL) closed at 5,325.00p on Thursday, marking an intraday increase 1.45 percent from the previous closing.
The company’s market capitalization has been reached £116.24 billion ($150.1 billion) at the end of today’s trading on the London Stock Exchange.
Latest Quarterly and Full Year Results
For the fourth quarter and full year ended December 31, 2025, Unilever reported underlying sales growth 3.9 percent quarterly once 3.5 percent throughout the year. The revenue for the year 2025 was recorded at €60.1 billioncompared to 60.8 billion in 2024, reflecting the impact of corporate abandonment. Underlying operating profit for the full year was flat €12.1 billionwith an effective limit of 20.0 percentrepresenting an improvement of 65 points over the previous year.
Segment performance (Subsidiary Sales Growth) for the last quarter is as follows:
- Beauty and Life: 5.1 percent
- Personal Care: 4.1 percent
- Home Care: 3.1 percent
- Nutritious Food (previously eaten): 3.4 percent
- Ice cream: 3.7 percent (reported as a separate group before completion of the merger)
FINANCIAL MATTERS
Full Year 2025 Results Summary
Unilever’s full-year 2025 results point towards margin expansion and volume-led growth. The volume growth in less than a year was 1.5 percentwhile price growth is calculated 2.0 percent. The company completed its plan to buy back 1.5 billion shares during the first half of the year. The shift to a more focused portfolio is evidenced by the growth of “power companies,” which now account for about 78 percent of the group’s profits.
Business & Operations Update
Unilever has completed the formal demerger of its Ice Cream business, which has started trading as a separate entity. The company also announced the sale of its Home Care business in Colombia and Ecuador to Alicorp and the divestiture of the Graze brand to Katjes International. To develop in-house capabilities, Unilever has invested £80 million in a new fragrance center in the UK. In addition, the company has appointed Srinivas Phatak as the Chief Financial Officer.
IM&A or Strategic Moves
The company has confirmed an annual M&A budget of approx €1.5 billionwith a primary strategic focus on the United States market. Recent activities include the discovery of a personal care brand for men Dr. Squatch. Additionally, a subsidiary of Hindustan Unilever Limited (HUL) announced the full acquisition of health brand OZiva, while simultaneously exiting its joint venture Nutritionalab (Wellbeing Nutrition).
Direction & Outlook
For the 2026 financial year, Unilever’s management expects sales growth below its multi-year target range. 4 to 6 percent. Factors to watch include the consolidation of recent acquisitions in the Beauty & Lifestyle segment and the impact of continued portfolio restructuring. The company expects modest improvement in operating margin as production plans continue to deliver cost savings.
Performance summary
Shares in Unilever PLC rose 1.45 percent following the announcement of full-year 2025 results. Underlying sales grew 3.5 percent year over year, supported by a 20.0 percent operating margin. Strategic initiatives for 2025 included an Ice Cream demerger and a focus on premium Power Brands, while 2026 guidance points to continued sales growth in the 4-6 percent range.
